Alok R. Singh
- Cancer Research top 10%
- Cancer, Hypoxia, and Metabolism 4
-
- Ubiquitin and proteasome pathways 6
- Protein Degradation and Inhibitors 5
- Histone Deacetylase Inhibitors Research 4
- PI3K/AKT/mTOR signaling in cancer 3
- Glycosylation and Glycoproteins Research 2
- Hematology top 10%
-
- Glioma Diagnosis and Treatment 3
-
- HIV/AIDS drug development and treatment 3
- Co-authors
- Shweta JoshiDonald L. DurdenMuamera ZulcicJitendra Kumar SaxenaJoseph R. GarlichGuillermo A. MoralesDaya Shankar PandeySanjay Kumar Singh
- Cited by
- Cancer ResearchImmunologyOncology
- Journals
- Proceedings of the National Academy of Sciences (1 paper)Journal of Biological Chemistry (1 paper)PLoS ONE (3 papers)
- Partner nations
- United StatesIndiaSpain
In The Last Decade
Alok R. Singh
25 papers receiving 856 citations
Peers
Comparison fields: 5 of 85
- Cancer Research 177
- Immunology 197
- Oncology 216
- Molecular Biology 494
- Hematology 78
Countries citing papers authored by Alok R. Singh
This map shows the geographic impact of Alok R. Singh's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alok R. Singh with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alok R. Singh more than expected).
Fields of papers citing papers by Alok R. Singh
This network shows the impact of papers produced by Alok R. Singh. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alok R. Singh. The network helps show where Alok R. Singh may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Alok R. Singh, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2022 | 10 | |
| 2 | 2019 | 41 | |
| 3 | 2017 | 98 | |
| 4 | 2017 | 27 | |
| 5 | 2016 | 51 | |
| 6 | 2016 | 23 | |
| 7 | 2015 | 23 | |
| 8 | 2015 | 2 | |
| 9 | 2014 | 104 | |
| 10 | 2014 | 14 | |
| 11 | 2014 | 93 | |
| 12 | 2014 | 20 | |
| 13 | 2014 | 113 | |
| 14 | 2013 | 14 | |
| 15 | 2012 | 9 | |
| 16 | 2009 | 16 | |
| 17 | 2008 | 23 | |
| 18 | 2008 | 26 | |
| 19 | 2007 | 9 | |
| 20 | 2007 | 73 |
About Alok R. Singh
Alok R. Singh is a scholar working on Cancer Research, Genetics and Molecular Biology, having authored 25 papers that have together received 858 indexed citations. Recurring topics across this work include Ubiquitin and proteasome pathways (6 papers), Protein Degradation and Inhibitors (5 papers), Cancer, Hypoxia, and Metabolism (4 papers), Histone Deacetylase Inhibitors Research (4 papers), Glioma Diagnosis and Treatment (3 papers), PI3K/AKT/mTOR signaling in cancer (3 papers), HIV/AIDS drug development and treatment (3 papers) and Glycosylation and Glycoproteins Research (2 papers). The work is most often cited by research in Cancer Research (177 citations), Immunology (197 citations) and Oncology (216 citations). Alok R. Singh has collaborated with scholars based in United States, India and Spain. Frequent co-authors include Shweta Joshi, Donald L. Durden, Muamera Zulcic, Jitendra Kumar Saxena, Joseph R. Garlich, Guillermo A. Morales, Daya Shankar Pandey, Sanjay Kumar Singh, Karen Messer and Lei Bao. Their work appears in journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and PLoS ONE.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.